ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Neuroprotection by dimethyl fumarate following ventral root crush in C57BL/6J mice
Brain Research Bulletin
◽
10.1016/j.brainresbull.2020.08.014
◽
2020
◽
Vol 164
◽
pp. 184-197
◽
Cited By ~ 1
Author(s):
Nahanna Zimmermann Menezes Carvalho
◽
Gabriela Bortolança Chiarotto
◽
Danielle Bernardes
◽
Paula Regina Gelinski Kempe
◽
Alexandre Leite Rodrigues Oliveira
Keyword(s):
Dimethyl Fumarate
◽
Ventral Root
Download Full-text
Related Documents
Cited By
References
Neuroprotection and immunomodulation by dimethyl fumarate and a heterologous fibrin biopolymer after ventral root avulsion and reimplantation
Journal of Venomous Animals and Toxins including Tropical Diseases
◽
10.1590/1678-9199-jvatitd-2019-0093
◽
2020
◽
Vol 26
◽
Cited By ~ 1
Author(s):
Paula R. G. Kempe
◽
Gabriela Bortolança Chiarotto
◽
Benedito Barraviera
◽
Rui Seabra Ferreira Jr.
◽
Alexandre L. R. de Oliveira
Keyword(s):
Dimethyl Fumarate
◽
Ventral Root
◽
Root Avulsion
◽
Ventral Root Avulsion
Download Full-text
Dimethyl Fumarate Named Allergen of the Year
Skin & Allergy News
◽
10.1016/s0037-6337(11)70097-3
◽
2011
◽
Vol 42
(3)
◽
pp. 11
Author(s):
DAMIAN McNAMARA
Keyword(s):
Dimethyl Fumarate
Download Full-text
Dimethyl fumarate (DMF) inhibits migration and proliferation of hepatocellular carcinoma (HCC)
10.1055/s-0039-3402232
◽
2020
◽
Author(s):
M Michalski
◽
O Wiesner
◽
M Müller-Schilling
◽
K Gülow
Keyword(s):
Hepatocellular Carcinoma
◽
Dimethyl Fumarate
Download Full-text
Dimethyl fumarate attenuates working memory deficits in both young and old rats in the streptozotocin-induced model of sporadic Alzheimer’s disease
10.26226/morressier.5785edcfd462b80296c99f5f
◽
2016
◽
Author(s):
Ewelina Kurowska
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Working Memory
◽
Dimethyl Fumarate
◽
Memory Deficits
◽
Sporadic Alzheimer’S Disease
◽
Old Rats
Download Full-text
Delayed-release dimethyl fumarate demonstrated no evidence of difference in clinical outcomes vs fingolimod in patients with RRMS: a propensity-matched comparative effectiveness analysis of the German NeuroTransData registry
10.26226/morressier.59a3eda8d462b8028d895362
◽
2017
◽
Author(s):
Stefan Braune
Keyword(s):
Clinical Outcomes
◽
Comparative Effectiveness
◽
Dimethyl Fumarate
◽
Delayed Release
◽
Effectiveness Analysis
◽
Comparative Effectiveness Analysis
Download Full-text
Efficacy of Delayed-release Dimethyl Fumarate in Newly Diagnosed Patients With Relapsing-Remitting Multiple Sclerosis: Eight-Year Follow-up of an Integrated Analysis of DEFINE, CONFIRM, and ENDORSE
10.26226/morressier.59a3eda8d462b8028d895222
◽
2017
◽
Cited By ~ 1
Author(s):
Ralf Gold
Keyword(s):
Multiple Sclerosis
◽
Dimethyl Fumarate
◽
Integrated Analysis
◽
Newly Diagnosed
◽
Delayed Release
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
An Evaluation of Adherence Using Panel Survey Data From Patients With Multiple Sclerosis Treated With Subcutaneous Interferon β-1a or Dimethyl Fumarate
10.26226/morressier.59a3edacd462b8028d895802
◽
2017
◽
Author(s):
Amy Perrin Ross
Keyword(s):
Multiple Sclerosis
◽
Survey Data
◽
Dimethyl Fumarate
◽
Panel Survey
◽
Interferon Β
◽
Panel Survey Data
Download Full-text
Effectiveness of Dimethyl Fumarate on Disease Activity and Patient-Reported Outcomes in French Subjects with Relapsing-Remitting Multiple Sclerosis in the Real-World: A Subgroup Analysis of PROTEC
10.26226/morressier.59a3edabd462b8028d8950aa
◽
2017
◽
Author(s):
Zeynep ['Brochet']
Keyword(s):
Multiple Sclerosis
◽
Disease Activity
◽
Real World
◽
Subgroup Analysis
◽
Patient Reported Outcomes
◽
Dimethyl Fumarate
◽
The Real
◽
Patient Reported
◽
Relapsing Remitting
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
Teriflunamide and dimethyl fumarate: results from clinical practice
10.26226/morressier.59a3e8b6d462b8028d895231
◽
2017
◽
Author(s):
Carlota Cunha
Keyword(s):
Clinical Practice
◽
Dimethyl Fumarate
Download Full-text
Delayed-release Dimethyl Fumarate Demonstrated No Difference in Clinical Outcomes versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: Results from the Real-world EFFECT Study
10.26226/morressier.59a3e8b6d462b8028d8951f5
◽
2017
◽
Cited By ~ 1
Author(s):
Jacob Sloane
Keyword(s):
Multiple Sclerosis
◽
Clinical Outcomes
◽
Real World
◽
Dimethyl Fumarate
◽
Effect Study
◽
The Real
◽
Delayed Release
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close